Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2018782185
Up to date per 10.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2018782185
Title / Product Name
VERFAHREN ZUR AUSWAHL EINER BEHANDLUNG FÜR KREBSPATIENTEN
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2018782185
EP Publication Number
3676404
E-Number
1833135
Language
EN
PCT Number
IB18056318
Publication Date
08.07.2020 A
03.09.2025 B1
Registration Date
03.09.2025
AT Publication Date
15.09.2025
Application Date
21.08.2018
Registration Number
-
Priorities
31.08.2017
US
201762552842 P
IPC
C12Q 1/6886 20180101AFI20241111BHEP
Maximum Duration of Protection
21.08.2038
Owner
Novartis AG
Lichtstrasse 35
4056 Basel
CH
Representative
No representatives present
Inventor
SU, Fei
c/o Novartis Pharmaceuticals Corporation One Health Plaza
East Hanover, New Jersey 07936
US
GERMA, Marie-Caroline
c/o Novartis Pharmaceuticals Corporation One Health Plaza
East Hanover, New Jersey 07936
US
MILLER, Michelle
c/o Novartis Pharmaceuticals Corporation One Health Plaza
East Hanover, New Jersey 07936
US
HE, Wei
c/o Novartis Institutes for Biomedical Research Inc. 220 Massachusetts Avenue
Cambridge, Massachusetts 02139
US
see.ip - Details for VERFAHREN ZUR AUSWAHL EINER BEHANDLUNG FÜR KREBSPATIENTEN